Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract

Details for Australian Patent Application No. 2005273592 (hide)

Owner GlaxoSmithKline Istrazivacki Centar Zagreb D.O.O.

Inventors Markovic, Stribor; Mercep, Mladen; Mesic, Milan; Tomaskovic, Linda

Agent Davies Collison Cave

Pub. Number AU-A-2005273592

PCT Pub. Number WO2006/018698

Priority 60/603,315 19.08.04 US; 60/601,087 12.08.04 US

Filing date 10 August 2005

Wipo publication date 23 February 2006

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/018698 Priority application(s): WO2006/018698

23 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005273609-Communication system

2005273560-Improved (low-volume) pneumatic atomiser and anti-drip device thereof